A Conversation with William Johnson, MD
Interview by Peter Wehrwein
A Conversation with Marty Makary, MD
Interview by Peter Wehrwein

News Wire

Zip Device Faster to Apply, Minimizes Scarring
Treatment Shorter, Less Complicated Than Typical Regimen
Researcher Made Himself Guinea Pig to Test the Drug
Statistically Significant Improvement in Excessive Daytime Sleepiness
DNA Changes May Help Predict Women at Risk
New Drug Could Make Ears “Young” Again
But a ‘Serendipitous’ Finding Could Provide a Solution
A Conversation with Ezekiel J. Emanuel, MD
Interview by Peter Wehrwein
The architect of the ACA waxes defiantly about how effective the law has been and what can be done to make it more so. Also, he is OK with Medicare for all but not the Sanders version.
Viewpoint
Lynn Barr
Even though misunderstandings abound, now is still a good time to take the plunge and become an ACO. New CMS rules have increased the chances of financial success.
Legislation & Regulation
Richard Mark Kirkner
All eyes are on the fate of Roe v. Wade, but the Trump administration’s Title X family planning rules are also the subject of a fierce legal battle.
News & Commentary
A prospective study in the works will track 1,500 to 2,000 patients undergoing checkpoint inhibitor therapy at clinics and hospitals across the nation. Researchers will collect blood samples periodically, subjecting the samples to genomics and other technologies that they hope will suss out causative biomarkers in those patients who develop diabetes.
News & Commentary
“That which does not kill us makes us stronger,” said Nietzsche. Goodness knows that the GOP and President Trump have been trying to kill the ACA, and/or replace it. There are battles on several fronts: legislative, judicial, political. Meanwhile the law lives on, but whether it’s stronger is…
CURRENT ISSUE August 2019

Hey! They’re Talking to You!

Ezekiel J. Emanuel, MD, and Andy Slavitt are two of eight Q&As in this ePub edition of Managed Care. You remember them, right? Emanuel invented the ACA and Slavitt helped launch it. They’re defiant, entertaining and erudite. Meanwhile, author Marty Makary, MD, offers a nice counterbalance to Emanuel and Slavitt by stating that disruptors, not politicians, hold the key. Also interviewed: Mei Wa Kwong of the Center for Connected Health Policy, William Johnson, MD, of Moda Health, and Daniel Knecht, MD, of Aetna. And a duo talk about a payer-provider partnership: Craig Samitt, MD, of Blue Cross Blue Shield of Minnesota, and J. Kevin Croston, MD, of North Memorial.

UPCOMING MEETINGS

San Diego, California
August 27-29, 2019
Scottsdale, AZ
September 09-10, 2019
Scottsdale, AZ
September 09-10, 2019
Scottsdale, AZ
September 16-17, 2019
Scottsdale, AZ
September 16-17, 2019
Las Vegas, NV
September 26-27, 2019
Las Vegas, NV
September 26-27, 2019
Chicago, IL
October 07-08, 2019
Alexandria, VA
October 16-17, 2019
News & Commentary
Racial disparity in the timely treatment of cancer effectively disappeared in states that expanded Medicaid under the ACA, according to the American Society of Clinical Oncology. Timely treatment was defined as starting first-line treatment within 30 days of a diagnosis for advanced or metastatic cancer.
Innovation ’19: Installment Plans for Drugs
Lola Butcher
An MIT-led collaboration is working on a pilot project on how to pay for Zolgensma—a $2.1 million gene therapy—in installments that are contingent on the drug living up to its curative promise.
Contributing Voices
Interview by Peter Wehrwein
Managed Care editor Peter Wehrwein interviews Epstein Becker Green's Jack Linehan on copay accumulators, copay coupons, and copay maximizers.  Transcript Peter Wehrwein: Hello, we are on the phone with Jack Linehan at Epstein Becker and Green. Jack has written several pieces for Managed Care about…
Innovation ’19: Diabetes Management
Lola Butcher
A program at Purdue succeeds by giving people with the disease many choices for how to manage the condition.